Terazosin HCl 1mg Capsule pdf
Size: 155 KB
Pages: n/a
Date: 2011-05-15
Related Documents
Size: 101 KB
Pages: 1
Date: 2013-03-12
Shirish Valsangikar Sr. Director, Quality Salisbury Office Direct Dial: 410-912-3709 Fax: 410-860-8719 Email: Shirish. Valsangikar cadista. com Website:.
Size: 89 KB
Pages: n/a
Date: 2011-12-17
HTMLCONTROL Forms. HTML:Hidden. 1 Nabilone 1mg Capsules Valeant Pharmaceuticals Ltd Table of Contents http://emc. medicines. org. aspx documentid 20515 companyid 758 l PRODUCTINFO.
Size: 107 KB
Pages: 13
Date: 2012-02-01
40-8791 DILTIAZE M HYDROCHLORIDE CAPSULES, USP Once-a-Day Dosage Revised June2011 Rx Only DESCRIPTION Diltiazem hydrochloride, USP is a calcium ion ce llular influx inhibitor.
Size: 107 KB
Pages: 13
Date: 2012-10-22
40-8791 DILTIAZE M HYDROCHLORIDE CAPSULES, USP Once-a-Day Dosage Revised June2011 Rx Only DESCRIPTION Diltiazem hydrochloride, USP is a calcium ion ce llular influx inhibitor.
Size: 107 KB
Pages: 13
Date: 2013-05-09
40-8791 DILTIAZE M HYDROCHLORIDE CAPSULES, USP Once-a-Day Dosage Revised June2011 Rx Only DESCRIPTION Diltiazem hydrochloride, USP is a calcium ion ce llular influx inhibitor.
Size: 93 KB
Pages: n/a
Date: 2011-03-20
Published 14 April 2009 Page 1 of 7 Scottish Medicines Consortium topotecan 0. 25mg, 1mg hard capsules HycamtinÒÒÒÒ No. 545/09 GlaxoSmithKline 06 March 2009.
Size: 1.1 MB
Pages: 2
Date: 2011-03-20
Size: 31 KB
Pages: 1
Date: 2011-12-30
Scottish Medicines Consortium tacrolimus 0. 5mg, 1mg, 5mg capsule Advagraf No. 402/07 Astellas Pharma Product Update 10 August 2007 The Scottish.
Size: 154 KB
Pages: n/a
Date: 2011-11-19
HTMLCONTROL Forms. HTML:Hidden. 1 26/05/2009 Prograf 0. 5mg, 1mg, 5mg Hard Capsules Table of Contents http://emc. medicines. org. aspx documentid 11102.
Size: 147 KB
Pages: 11
Date: 2012-11-02
The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in September2009 HYCAMTIN CAPSULES TITLE Topotecan hydrochloride. SCOPE.
Size: 28 KB
Pages: 6
Date: 2010-12-30
MSDS : 035/00 Page 1 of 6 Effective Date : 04/07/2009 1. I DENTIFICATION OF THE SUBSTANCE AND THE COMPANY 2. C OMPOSITION / INFORMAT ION ON INGREDIENTS 3. H AZARD IDENTIFICATION Material Amlodipine.
Size: 76 KB
Pages: 2
Date: 2011-05-29
Size: 76 KB
Pages: 2
Date: 2011-10-29
Size: 28 KB
Pages: 7
Date: 2011-10-20
MSDS : 035/02 Page 1 of 7 Effective Date : 25/04/2011 1. I DENTIFICATION OF THE SUBSTANCE AND THE COMPANY 2. C OMPOSITION / INFORMAT ION ON INGREDIENTS 3. H AZARD IDENTIFICATION Material Amlodipine.
Size: 79 KB
Pages: 1
Date: 2011-12-08
Contacts: Robert Jaffe Pondel WilkinsonInc. 310 279-5980 RECEIVES FDA APPROV AL FOR PHENTERMINE HCLCAPSULES, 37. 5MG Philadelphia,PA ± July 20, 2011 ± Lannett Company, Inc. NYSE.
Size: 76 KB
Pages: 2
Date: 2012-10-22
Size: 79 KB
Pages: 1
Date: 2012-10-22
Contacts: Robert Jaffe Pondel WilkinsonInc. 310 279-5980 RECEIVES FDA APPROV AL FOR PHENTERMINE HCLCAPSULES, 37. 5MG Philadelphia,PA ± July 20, 2011 ± Lannett Company, Inc. NYSE.
Size: 126 KB
Pages: 6
Date: 2013-05-22
Material Safety data sheet Tamsulosin Hydrochloride Capsules Strength:0. 4mgNDC 68382-132-06 in bottle of 30 capsules. NDC 68382-132-14 in bottle of 60 capsules NDC 68382-132-16.
Size: 22 KB
Pages: 2
Date: 2013-03-29
Lannett Receives FDA Approval for Phentermine HCl Capsules, 37. 5 mg Lannett Company, Inc. NYSE AMEX: LCI today announced that it has received approval from the U. S. Food.
Size: 482 KB
Pages: 1
Date: 2013-03-20
Size: 414 KB
Pages: 6
Date: 2012-12-29
319 of Advances in Pharmaceutical Sciences Issue 5 September - October 2012 Ava ilable online: www. pharmanest. net ISSN2231-0541 PHARMANEST Volume3 Issue 5 September - October.


Comments (not logged in)